Paper · 20174895
Papillary carcinoma tall cell variant (TCV): a review.
LiVolsi VA. Endocr Pathol, 2010. Cited by 52 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Papillary carcinoma tall cell variant (TCV): a review. Papers, record 20174895. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20174895
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics3
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Papillary | Major topic |
| Thyroid Neoplasms | Major topic |
| Humans |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| U01 CA044974 | NCI NIH HHS | United States | U01CA044974 | PubMed and NIH |
Source NIH RePORTER
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References20
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10,760,768 | Prognostic significance of histologic grading compared with subclassification of papillary thyroid carcinoma. | Cancer | 2000 | https://conductscience.org/library/papers/10760768 | PubMed |
| 2 | 18,925,842 | Papillary thyroid carcinoma tall cell variant. | Thyroid | 2008 | https://conductscience.org/library/papers/18925842 | PubMed |
| 3 | 16,434,896 | Correlation between genetic alterations and microscopic features, clinical manifestations, and prognostic characteristics of thyroid papillary carcinomas. | Am J Surg Pathol | 2006 | https://conductscience.org/library/papers/16434896 | PubMed |
| 4 | 1,468,777 | Distribution of the 72-kd type IV collagenase in nonneoplastic and neoplastic thyroid tissue. | Hum Pathol | 1992 | https://conductscience.org/library/papers/1468777 | PubMed |
| 5 | 1,000,814 | The many appearances of papillary carcinoma of the thyroid. | Cleve Clin Q | 1976 | https://conductscience.org/library/papers/1000814 | PubMed |
| 6 | 1,722,043 | Spindle cell squamous carcinoma of the thyroid: an unusual anaplastic tumor associated with tall cell papillary cancer. | Mod Pathol | 1991 | https://conductscience.org/library/papers/1722043 | PubMed |
| 7 | 15,172,984 | Genome-wide profiling of papillary thyroid cancer identifies MUC1 as an independent prognostic marker. | Cancer Res | 2004 | https://conductscience.org/library/papers/15172984 | PubMed |
| 8 | 17,097,131 | Prevalence and prognostic significance of tall cell variant of papillary thyroid carcinoma. | Hum Pathol | 2007 | https://conductscience.org/library/papers/17097131 | PubMed |
| 9 | 18,684,023 | The thyroid Hürthle (oncocytic) cell and its associated pathologic conditions: a surgical pathology and cytopathology review. | Arch Pathol Lab Med | 2008 | https://conductscience.org/library/papers/18684023 | PubMed |
| 10 | 8,712,296 | Tall cell variant of papillary thyroid carcinoma: a reassessment and immunohistochemical study with comparison to the usual type of papillary carcinoma of the thyroid. | Am J Surg Pathol | 1996 | https://conductscience.org/library/papers/8712296 | PubMed |
1 to 10 of 20
See all 20 referencesCited by29
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 52 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39,470,763 | Construction and validation of a nomogram for predicting cervical lymph node metastasis in tall cell variant of papillary thyroid carcinoma. | Eur Arch Otorhinolaryngol | 2025 | https://conductscience.org/library/papers/39470763 | PubMed |
| 38,775,639 | Predicting tall-cell subtype of papillary thyroid carcinomas independently with preoperative multimodal ultrasound. | Br J Radiol | 2024 | https://conductscience.org/library/papers/38775639 | PubMed |
| 37,894,308 | The Incidence Trend and Management of Thyroid Cancer-What Has Changed in the Past Years: Own Experience and Literature Review. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37894308 | PubMed |
| 37,864,666 | A Critical Assessment of Diagnostic Criteria for the Tall Cell Subtype of Papillary Thyroid Carcinoma-How Much? How Tall? And When Is It Relevant? | Endocr Pathol | 2023 | https://conductscience.org/library/papers/37864666 | PubMed |
| 37,497,347 | Warthin-like papillary thyroid carcinoma: a case report and comprehensive review of the literature. | Front Endocrinol (Lausanne) | 2023 | https://conductscience.org/library/papers/37497347 | PubMed |
| 37,435,919 | Application of thyroglobulin and anti-thyroglobulin antibody combined with emission computed tomography in the adjuvant diagnosis of differentiated thyroid carcinoma. | Ann Med | 2023 | https://conductscience.org/library/papers/37435919 | PubMed |
| 35,242,669 | Comparison of the clinicopathological features and oncologic outcomes of the classic papillary thyroid carcinoma with tall cell features and tall cell variant. | Gland Surg | 2022 | https://conductscience.org/library/papers/35242669 | PubMed |
| 33,669,363 | Thyroid Carcinoma: Phenotypic Features, Underlying Biology and Potential Relevance for Targeting Therapy. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33669363 | PubMed |
| 33,520,545 | Warthin-Like Variant of Papillary Thyroid Carcinoma: An Uncommon Variant. | Cureus | 2020 | https://conductscience.org/library/papers/33520545 | PubMed |
| 33,379,135 | Tall Cell Variant versus Conventional Papillary Thyroid Carcinoma: A Retrospective Analysis in 351 Consecutive Patients. | J Clin Med | 2020 | https://conductscience.org/library/papers/33379135 | PubMed |
1 to 10 of 29
See all 29 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20174895
GET https://conductscience.org/api/papers/v1/20174895/cited_by?page=2